沃华医药
(002107)
| 流通市值：24.84亿 | | | 总市值：25.17亿 |
| 流通股本：5.70亿 | | | 总股本：5.77亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 909,506,771.72 | 716,392,429.5 | 492,309,107.65 | 235,281,203.05 |
| 营业收入 | 909,506,771.72 | 716,392,429.5 | 492,309,107.65 | 235,281,203.05 |
| 二、营业总成本 | 857,005,532.26 | 670,903,250.25 | 462,511,619.01 | 212,158,583.49 |
| 营业成本 | 232,437,403.26 | 175,254,201.15 | 119,985,563.43 | 57,788,565.81 |
| 税金及附加 | 15,192,060.57 | 11,817,119.35 | 8,284,753.01 | 3,794,902.29 |
| 销售费用 | 491,771,935.18 | 396,000,546.49 | 270,723,084.38 | 117,466,712.37 |
| 管理费用 | 77,348,443.63 | 55,057,458.8 | 37,001,714.92 | 18,772,532.32 |
| 研发费用 | 45,354,777.71 | 36,523,429.87 | 29,019,211.81 | 15,552,459.72 |
| 财务费用 | -5,099,088.09 | -3,749,505.41 | -2,502,708.54 | -1,216,589.02 |
| 其中:利息费用 | 35,435.28 | 29,531.49 | 21,590.04 | 11,733.95 |
| 其中:利息收入 | 5,227,891.79 | 3,830,402.75 | 2,562,591.64 | 1,256,245.89 |
| 资产减值损失(新) | -2,307,917.72 | -2,146,353.36 | -1,614,389.99 | -202,153.75 |
| 信用减值损失(新) | 1,235,548.09 | 1,531,396.45 | 1,038,180.6 | 1,266,261.6 |
| 其他收益 | 5,061,001.75 | 2,839,784.25 | 2,024,226.2 | 1,042,239.41 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 56,489,871.58 | 47,714,006.59 | 31,245,505.45 | 25,228,966.82 |
| 加:营业外收入 | 1,040,871.09 | 884,311.11 | 521,566.31 | 21,831.31 |
| 减:营业外支出 | 2,892,573.53 | 386,425.23 | 351,709.64 | 5,579.63 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 54,638,169.14 | 48,211,892.47 | 31,415,362.12 | 25,245,218.5 |
| 减:所得税费用 | 8,010,616.94 | 1,773,603.76 | 1,850,881.91 | 3,013,328.5 |
| 六、净利润 | 46,627,552.2 | 46,438,288.71 | 29,564,480.21 | 22,231,890 |
| 持续经营净利润 | 46,627,552.2 | 46,438,288.71 | 29,564,480.21 | 22,231,890 |
| 归属于母公司股东的净利润 | 58,767,086.78 | 57,401,272.79 | 37,203,988.86 | 25,449,286.76 |
| 少数股东损益 | -12,139,534.58 | -10,962,984.08 | -7,639,508.65 | -3,217,396.76 |
| (一)基本每股收益 | 0.1 | 0.1 | 0.06 | 0.04 |
| (二)稀释每股收益 | 0.1 | 0.1 | 0.06 | 0.04 |
| 九、综合收益总额 | 46,627,552.2 | 46,438,288.71 | 29,564,480.21 | 22,231,890 |
| 归属于母公司股东的综合收益总额 | 58,767,086.78 | 57,401,272.79 | 37,203,988.86 | 25,449,286.76 |
| 归属于少数股东的综合收益总额 | -12,139,534.58 | -10,962,984.08 | -7,639,508.65 | -3,217,396.76 |
| 公告日期 | 2024-03-30 | 2023-10-27 | 2023-07-29 | 2023-04-27 |
| 审计意见(境内) | 标准无保留意见 | | | |